On July 16, 2021, NICE announced a new approach to prioritizing requests for NICE Scientific Advice. Because of the increased engagement, the waiting time for new scientific advice projects is currently several months. To address this, from December 2021, NICE will reserve priority slots in the work plan for companies developing high-priority technologies for the NHS.
NICE Scientific Advice’s services will still be available to all companies, and requests for advice will not be rejected through the prioritization process. The only difference is that if the product meets the criteria for a priority slot, NICE will initiate that project faster.
Regardless of how their technology might be prioritized, all companies are encouraged to contact NICE as early as possible. In addition to this prioritization system, NICE also increases capacity within the team to better meet the demand for all projects.
NICE Scientific Advice will continue to review this new approach based on demand for their services and feedback from companies, and they welcome companies to share their views by emailing scientificadvice@nice.org.uk
See the full details here. Prioritization criteria can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).